powerful collaborations, cutting-edge science, and curious minds coming together for a glimpse of the future.

Stay tuned as we look at the latest updates on some of the most promising technology projects.

Welcome to the EUvation podcast. I'm Peter Balland from Technicon. Today we once again look at the

IPC project. IPC stands for individualized pediatric cure. This is a huge EU-funded effort to

assist doctors in finding the most effective treatment for children with

tumors. There is no one-size-fits-all approach, and doctors, clinicians, oncologists,

biomedical engineers, and computer scientists are working together in IPC to use data, human samples,

and artificial intelligence to tailor treatments for kids while

minimizing the risks. It's no easy task, but IPC is making inroads in this area. Today we speak

with Mateo Monica from project partner IBM. He's a research staff member at the IBM Research Lab

in Europe at the Zurich location. In the wake of the COVID-19 restrictions, we speak with Matteo remotely from his home office in Zurich.

Welcome to the show and tell us about IPC and your specific role in the project.

IPC is a European project about the development of precise and precision medicine solution

for pediatric tumors.

The main motivation behind this project is that these type of tumors are quite rare, but when they

happens, usually we don't have effective or efficient treatments to handle this type of tumors.

We obviously focus on curing the disease and ensuring the survival of the patient,

but a lot of the treatment options that we have might have extremely negative side effects on the long term.

So we might put the patient through a life and long-term serious health consequences.

So the main reason behind working on these specific tumors in IPC is to try to optimize and find better

therapists that might work as well as current therapies are doing but the idea is

that we might try to tailor them on the specific patient in order to have a better

...